Also, clustering participants based on the relationship between tau spreading and functional disconnection may have a practical value for biomedical research, particularly by allowing clinical trials to quantify heterogeneity across the spectrum of Alzheimer’s disease. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.